Diagnostic efficacy of 18F-FAPI-74 PET/CT in patients with colon cancer

Brief summary (registry, in English)

To assess the accuracy of 18F-FAPI-74 PET/CT in detection of local lymph node metastasis in patients with primary colon cancer

What you commit to

• Study type: Interventional · Phase 2
• Planned participants: 100
• 1 site in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

AI-kivonat: who the study is looking for

Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with primary colon cancer who may have spread to nearby lymph nodes or elsewhere, to test how well an 18F-FAPI-74 PET/CT scan finds it.

Age

18 years or older

Sex

All sexes can join

Disease stage

Primary colon cancer with suspected spread to lymph nodes in the abdomen on a CT scan before surgery; or cancer spread that may be treatable; or suspected spread or return of cancer on CT and/or a raised CEA level during follow-up

Biomarker or test result

A raised carcinoembryonic antigen (CEA) level is one way to join, during cancer follow-up

Main reasons for not taking part

• Disabled people, children, prisoners
• Pregnant or breast-feeding women
• Cannot understand the purpose of the study
• Medical conditions that rule out a whole body PET-CT

Read by machine on 9 Nov 2026.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

Are you the coordinator? Confirm the details